Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Henderberg

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Mycopathologia|January 1, 1989
Sterigmatocystin production on complex and defined substratesJ W Bennett, A Henderberg, K Grossman
The Journal of Antimicrobial Chemotherapy|September 1, 1990
In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agentsK E Aldridge, A Henderberg, C V Sanders
Journal of General Microbiology|March 1, 1988
Biosynthetic origin of aflatoxin G1: confirmation of sterigmatocystin and lack of confirmation of aflatoxin B1 as precursorsA Henderberg, J W Bennett, L S Lee
The Journal of Antimicrobial Chemotherapy|May 1, 1990
Enhanced antimicrobial activity of old and new beta-lactams against cefoxitin-resistant Bacteroides fragilis group isolates by beta-lactamase inhibitorsK E Aldridge, A Henderberg, C V Sanders
Diagnostic Microbiology and Infectious Disease|May 1, 1989
Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosaK E Aldridge, A Henderberg, C V Sanders
Journal of Clinical Microbiology|February 1, 1990
Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolatesK E Aldridge, A Henderberg, D D Schiro, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1989
Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistanceK E Aldridge, A Henderberg, K Gebbia, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1994
A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United StatesK E Aldridge, M Gelfand, L B Reller, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Mycopathologia|January 1, 1989
Sterigmatocystin production on complex and defined substratesJ W Bennett, A Henderberg, K Grossman
The Journal of Antimicrobial Chemotherapy|September 1, 1990
In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agentsK E Aldridge, A Henderberg, C V Sanders
Journal of General Microbiology|March 1, 1988
Biosynthetic origin of aflatoxin G1: confirmation of sterigmatocystin and lack of confirmation of aflatoxin B1 as precursorsA Henderberg, J W Bennett, L S Lee
The Journal of Antimicrobial Chemotherapy|May 1, 1990
Enhanced antimicrobial activity of old and new beta-lactams against cefoxitin-resistant Bacteroides fragilis group isolates by beta-lactamase inhibitorsK E Aldridge, A Henderberg, C V Sanders
Diagnostic Microbiology and Infectious Disease|May 1, 1989
Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosaK E Aldridge, A Henderberg, C V Sanders
Journal of Clinical Microbiology|February 1, 1990
Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolatesK E Aldridge, A Henderberg, D D Schiro, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1989
Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistanceK E Aldridge, A Henderberg, K Gebbia, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1994
A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United StatesK E Aldridge, M Gelfand, L B Reller, et al.
Pageof 1